600812 华北制药
已收盘 05-13 15:00:00
资讯
新帖
简况
【关注】华北制药冲击首仿,超30亿市场掀波澜
米内网 · 08:54
【关注】华北制药冲击首仿,超30亿市场掀波澜
华北制药控股股东冀中集团解除9915万股冻结
财中社 · 08:36
华北制药控股股东冀中集团解除9915万股冻结
华北制药05月12日遭主力抛售293.5万元
市场透视 · 05-12 07:20
华北制药05月12日遭主力抛售293.5万元
化学制药行业盘中拉升,复旦复华涨5.49%
市场透视 · 05-09
化学制药行业盘中拉升,复旦复华涨5.49%
华北制药05月08日遭主力抛售7.2万元
市场透视 · 05-08
华北制药05月08日遭主力抛售7.2万元
华北制药股东解除质押3000万股
财中社 · 05-07
华北制药股东解除质押3000万股
华北制药05月07日遭主力抛售690.7万元
市场透视 · 05-07
华北制药05月07日遭主力抛售690.7万元
华北制药04月29日获主力加仓3522万元
市场透视 · 04-29
华北制药04月29日获主力加仓3522万元
河北森暖商贸有限公司中标华北制药股份有限公司倍达分厂食材采购项目
iDoNews · 04-26
河北森暖商贸有限公司中标华北制药股份有限公司倍达分厂食材采购项目
华北制药(600812)3月31日股东户数8.74万户,较上期减少0.16%
证券之星 · 04-24
华北制药(600812)3月31日股东户数8.74万户,较上期减少0.16%
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
制药网 · 04-24
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
华北制药、浙江医药等4家药企一季度实现业绩翻倍增长
动脉网 · 04-24
华北制药、浙江医药等4家药企一季度实现业绩翻倍增长
AACR即将开幕,医药或迎密集催化
Ofweek维科网 · 04-24
AACR即将开幕,医药或迎密集催化
华北制药控股子公司华胜公司实施3亿元定向减资
财中社 · 04-23
华北制药控股子公司华胜公司实施3亿元定向减资
华北制药(600812.SH)发布一季度业绩,归母净利润5749.16万元,同比增长216.72%
智通财经 · 04-23
华北制药(600812.SH)发布一季度业绩,归母净利润5749.16万元,同比增长216.72%
华北制药一季度归母净利润同比增216.7%至5749万元
财中社 · 04-23
华北制药一季度归母净利润同比增216.7%至5749万元
加载更多
公司概况
公司名称:
华北制药股份有限公司
所属行业:
医药制造业
上市日期:
1994-01-14
主营业务:
华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染类、肾病及免疫调节类、心脑血管类、维生素及健康消费品、神经、血液系统用药、医药中间体、防疫类、农药、兽药类、医药及其它物流贸易。公司是首批国家认定企业技术中心、国家“863计划”成果产业化基地、中国青年科技创新行动示范基地、微生物药物国家工程研究中心、抗体药物研制国家重点实验室、抗生素酶催化与结晶技术国家地方联合工程实验室。
发行价格:
4.00
{"stockData":{"symbol":"600812","market":"SH","secType":"STK","nameCN":"华北制药","latestPrice":5.95,"timestamp":1747119600000,"preClose":5.99,"halted":0,"volume":11624370,"delay":0,"changeRate":-0.0067,"floatShares":1716000000,"shares":1716000000,"eps":0.097,"marketStatus":"已收盘","change":-0.04,"latestTime":"05-13 15:00:00","open":6.01,"high":6.04,"low":5.94,"amount":69459600,"amplitude":0.0167,"askPrice":5.96,"askSize":290,"bidPrice":5.95,"bidSize":4951,"shortable":0,"etf":0,"ttmEps":0.097,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747186200000},"marketStatusCode":5,"adr":0,"adjPreClose":5.99,"symbolType":"stock","openAndCloseTimeList":[[1747099800000,1747107000000],[1747112400000,1747119600000]],"highLimit":6.59,"lowLimit":5.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1715730370,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":61.340206,"roe":"1.061%","epsLYR":0.074,"committee":0.273457,"marketValue":10209000000,"turnoverRate":0.0068,"status":1,"floatMarketCap":10209000000},"requestUrl":"/m/hq/s/600812","defaultTab":"news","newsList":[{"id":"2535858772","title":"【关注】华北制药冲击首仿,超30亿市场掀波澜","url":"https://stock-news.laohu8.com/highlight/detail?id=2535858772","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535858772?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:54","pubTimestamp":1747126483,"startTime":"0","endTime":"0","summary":"精彩内容5月13日,CDE官网显示,华北制药的甲磺酸沙非胺片以仿制4类报产在审。米内网数据显示,抗帕金森氏病化药在2024年中国三大终端六大市场(统计范围见文末)销售规模超过30亿元。今年以来,华北制药已有5款产品报产在审。甲磺酸沙非胺片适用于原发性帕金森病伴症状波动(包括剂末恶化和开-关现象)成人患者的联合治疗(与左旋多巴合用,或与左旋多巴及其他帕金森病药物合用)。近年中国零售药店终端抗帕金森氏病化药销售情况(单位:万元)来源:米内网格局数据库","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513214454a6dda3b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513214454a6dda3b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","BK0028","600812"],"gpt_icon":0},{"id":"2535610748","title":"华北制药控股股东冀中集团解除9915万股冻结","url":"https://stock-news.laohu8.com/highlight/detail?id=2535610748","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535610748?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:36","pubTimestamp":1747125416,"startTime":"0","endTime":"0","summary":"5月13日,华北制药发布公告,控股股东冀中能源集团有限责任公司于2025年5月12日解除其所持有的9915万股冻结。解除冻结后,冀中集团及其一致行动人冀中能源股份有限公司和华北制药集团有限责任公司累计被冻结的股份数量为0股。截至公告披露日,冀中集团持有公司股份1.89亿股,占公司总股本的11.02%。2025年一季度,华北制药实现收入25.74亿元,归母净利润5749万元。文章来源:财中社华北制药控股股东冀中集团解除9915万股冻结","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513164905a6dd4404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513164905a6dd4404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","BK0028","600812"],"gpt_icon":0},{"id":"2534108226","title":"华北制药05月12日遭主力抛售293.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534108226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534108226?lang=zh_cn&edition=full","pubTime":"2025-05-12 15:20","pubTimestamp":1747034407,"startTime":"0","endTime":"0","summary":"05月12日, 华北制药股价跌0.33%,报收5.99元,成交金额6633.5万元,换手率0.65%,振幅1.50%,量比0.80。华北制药今日主力资金净流出293.5万元,连续5日净流出,上一交易日主力净流出106.2万元。该股近5个交易日下跌0.99%,主力资金累计净流出1809.1万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出3391.0万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165936a6dbf980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165936a6dbf980&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0191","600812","BK0028"],"gpt_icon":0},{"id":"2534914047","title":"化学制药行业盘中拉升,复旦复华涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534914047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534914047?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:35","pubTimestamp":1746754541,"startTime":"0","endTime":"0","summary":"05月09日,化学制药行业盘中拉升,截至09点35分,化学制药行业整体指数上涨0.69%,报11095.540点。从个股上来看,该行业的成分股中,复旦复华涨5.49%,舒泰神涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为1308.51万,其中复旦复华受到资金热捧,主力净流入1798.12万;拉长时间线来看,该板块近20日主力资金净流入-53.31亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","603707","BK0028","600624","605177","688117","603367","688506","605507","600216","603669","BK0175","605116","600267","600521","600513","603229","BK0185","BK0239","688166","600488","600420","BK0122","600613","688566","688578","603168","600079","600062","688189","600200","BK0010","601089","BK0188","600812","600380","BK0075"],"gpt_icon":0},{"id":"2533373970","title":"华北制药05月08日遭主力抛售7.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533373970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533373970?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:19","pubTimestamp":1746688798,"startTime":"0","endTime":"0","summary":"05月08日,华北制药股价收平报6.06元,成交金额6954.3万元,换手率0.67%,振幅0.99%,量比0.58。华北制药今日主力资金净流出7.2万元,连续3日净流出,上一交易日主力净流出690.7万元。|05月08日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST双成|8.61%|#|跨境通|7.99%|#|中百集团|7.29%|#|...|...|#2545|华北制药|-0.00%|华北制药所在的化学制药行业,今日主力净流出8672万元,行业排名42/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508165707a6d7628e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508165707a6d7628e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812","BK0028","BK0191","BK0239"],"gpt_icon":0},{"id":"2533677676","title":"华北制药股东解除质押3000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533677676","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533677676?lang=zh_cn&edition=full","pubTime":"2025-05-07 16:47","pubTimestamp":1746607620,"startTime":"0","endTime":"0","summary":"5月7日,华北制药(600812)发布公告,股东华北制药集团有限责任公司解除质押3000万股,占其持股的8.79%及公司总股本的1.75%。截至公告披露日,华药集团及其一致行动人累计质押1.7亿股,占合计持股的18.01%及公司总股本的9.91%。2025年一季度,华北制药实现收入25.74亿元,归母净利润5749万元。(文章来源:财中社)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050716503794ef0aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050716503794ef0aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","600812","BK0028","BK0239"],"gpt_icon":0},{"id":"2533677606","title":"华北制药05月07日遭主力抛售690.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533677606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533677606?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:21","pubTimestamp":1746602467,"startTime":"0","endTime":"0","summary":"05月07日, 华北制药股价跌0.49%,报收6.06元,成交金额9809.4万元,换手率0.94%,振幅1.81%,量比0.74。华北制药今日主力资金净流出690.7万元,上一交易日主力净流出711.6万元。|05月07日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST精伦|9.01%|#|长华化学|6.32%|#|*ST国华|6.24%|#|...|...|#3045|华北制药|-0.07%|华北制药所在的化学制药行业,今日主力净流出5.40亿元,行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170225a6d61caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170225a6d61caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600812","BK0239","BK0191"],"gpt_icon":0},{"id":"2531627544","title":"华北制药04月29日获主力加仓3522万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531627544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531627544?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:19","pubTimestamp":1745911166,"startTime":"0","endTime":"0","summary":"04月29日, 华北制药股价涨3.76%,报收6.07元,成交金额2.2亿元,换手率2.09%,振幅6.84%,量比1.38。华北制药今日主力资金净流入3522万元,连续3日净流入,上一交易日主力净流入26万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为11.11%,平均涨幅为10.08%。|04月29日主力加仓幅度排名||#|股票简称|主力净额占比|#|红墙股份|7.84%|#|塞力医疗|6.27%|#|东珠生态|5.34%|#|...|...|#329|华北制药|0.34%|华北制药所在的化学制药行业,今日主力净流出5.20亿元,行业排名5/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429161404a6cce886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429161404a6cce886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2530514260","title":"河北森暖商贸有限公司中标华北制药股份有限公司倍达分厂食材采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2530514260","media":"iDoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530514260?lang=zh_cn&edition=full","pubTime":"2025-04-26 17:18","pubTimestamp":1745659082,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年04月25日,河北森暖商贸有限公司成功中标华北制药股份有限公司倍达分厂的员工食堂2025米粮佐料类食材采购(第3次采购)项目。该项目中标金额为275816.83168317元。此次中标结果公告由华北制药股份有限公司倍达分厂发布。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042617191097462a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042617191097462a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812","BK0191","BK0028","BK0239"],"gpt_icon":0},{"id":"2529604590","title":"华北制药(600812)3月31日股东户数8.74万户,较上期减少0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529604590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529604590?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:11","pubTimestamp":1745485860,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华北制药(维权)披露,截至2025年3月31日公司股东户数为8.74万户,较2月28日减少142.0户,减幅为0.16%。 在化学制药行业个股中,华北制药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.15万户。 从股价来看,2025年2月28日至2025年3月31日,华北制药区间跌幅为1.44%,在此期间股东户数减少142.0户,减幅为0.16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-24/doc-ineuhiqv2858541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","600812","BK0028","BK0191"],"gpt_icon":0},{"id":"2529793817","title":"AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2529793817","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529793817?lang=zh_cn&edition=full","pubTime":"2025-04-24 14:57","pubTimestamp":1745477831,"startTime":"0","endTime":"0","summary":"自 AI 技术开始应用于药物研发以来,AI 驱动的药物管线数量呈现出爆发式增长。如今,全球范围内已有 102 个 AI 驱动的药物管线获批临床试验,其中56个处于Ⅰ期、41个处于Ⅱ期、5个处于Ⅲ期,涵盖了多种疾病领域,包括肿瘤、神经系统疾病、心血管疾病等。一些用于治疗心律失常、心力衰竭等心血管疾病的 AI 驱动药物管线,正在临床试验中接受进一步验证,有望为心血管疾病患者提供更有效的治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600420","BK0168","688076","603538","603669","688566","BK0188","688578","600851","600380","600267","603676","BK0239","603367","600488","603351","600521","605116","600812","605507","600062","600216","BK0046","688117","601089","688658","688799","600789"],"gpt_icon":0},{"id":"2529404936","title":"华北制药、浙江医药等4家药企一季度实现业绩翻倍增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2529404936","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529404936?lang=zh_cn&edition=full","pubTime":"2025-04-24 14:16","pubTimestamp":1745475360,"startTime":"0","endTime":"0","summary":"2025年一季度,华北制药、浙江医药、金凯生科和赛升药业四家药企实现业绩翻倍增长。浙江医药净利润同比增长273.08%,主要得益于维生素E和维生素A系列产品销售价格上涨;华北制药通过全面预算管控和精益管理,净利润同比增长216.72%;金凯生科作为小分子CDMO服务商,营收同比增长41.83%,净利润同比增长183.24%,归功于订单增加和成本控制;赛升药业尽管营业收入下降15.52%,但净利润同比增长120.97%。这些企业的业绩增长反映了其在市场拓展、成本控制和运营效率提升方面的显著成效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424142221974321da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424142221974321da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600216","600812","BK0239","BK0191","BK0028"],"gpt_icon":0},{"id":"2529462576","title":"AACR即将开幕,医药或迎密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462576","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462576?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:19","pubTimestamp":1745464762,"startTime":"0","endTime":"0","summary":"AACR将于当地时间4月25日至4月30日在美国费城召开,本次会议将有近100家中国药企亮相,带来超200项新药研究结果。恒瑞医药、科伦博泰、信达生物、百利天恒、再鼎医药、复宏汉霖、乐普生物等有望发布重要ADC数据,涉及诸多靶点,中国ADC技术有望在国际舞台崭露头角。近年来,国内创新药在AACR会议上的影响力持续攀升,ADC之外,双抗及小分子疗法市场关注度也较高,或带来更多消息面的催化,恒生医药ETF已连续5日上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688578","688505","BK0012","605116","605507","688799","603676","688506","688602","688091","688566","688658","600664","603669","BK0196","600216","600420","BK0096","600488","BK0028","688076","688166","600789","BK0239","BK0060","BK0187","600380","BK0183","603538","600267","BK0188","600521","159938","603351","600812","688247","600062","601089","BK0175","603367","600196"],"gpt_icon":0},{"id":"2529075335","title":"华北制药控股子公司华胜公司实施3亿元定向减资","url":"https://stock-news.laohu8.com/highlight/detail?id=2529075335","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529075335?lang=zh_cn&edition=full","pubTime":"2025-04-23 20:17","pubTimestamp":1745410677,"startTime":"0","endTime":"0","summary":"4月23日,华北制药发布公告,公司控股子公司华北制药华胜有限公司将实施定向减资,建信金融资产投资有限公司将退出华胜公司,持股比例将由47.7389%降至0%。本次减资由建信投资单方进行,华胜公司的注册资本将从2.37亿元减少至1.24亿元。公告中提到,减资完成后不会导致公司的合并报表范围发生变更,且对华胜公司的经营情况及公司未来的财务状况和经营成果不会产生重大影响。2024年,华北制药实现收入98.70亿元,归母净利润1.27亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042320181597421b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042320181597421b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812","BK0191","BK0239","BK0028"],"gpt_icon":0},{"id":"2529262506","title":"华北制药(600812.SH)发布一季度业绩,归母净利润5749.16万元,同比增长216.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529262506","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529262506?lang=zh_cn&edition=full","pubTime":"2025-04-23 19:19","pubTimestamp":1745407144,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华北制药(600812.SH)发布2025年第一季度报告,公司2025年第一季度营业收入25.74亿元,同比增长0.65%;归属于上市公司股东的净利润5749.16万元,同比增长216.72%;归属于上市公司股东的扣除非经常性损益的净利润5521.53万元,同比增长376.62%;基本每股收益0.034元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600812"],"gpt_icon":0},{"id":"2529750626","title":"华北制药一季度归母净利润同比增216.7%至5749万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529750626","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529750626?lang=zh_cn&edition=full","pubTime":"2025-04-23 19:01","pubTimestamp":1745406095,"startTime":"0","endTime":"0","summary":"4月23日,华北制药公布2025年一季报,公司营业收入为25.7亿元,同比上升0.7%;归母净利润为5749万元,同比上升216.7%;扣非归母净利润为5522万元,同比上升376.6%;经营现金流净额为1.63亿元,同比下降71.2%;EPS为0.0335元。截至一季度末,公司总资产219.94亿元,较上年度末增长2.4%;归母净资产为54.48亿元,较上年度末增长1.1%。此外,公司的总资产在报告期末达到219.94亿元,表明其资产规模有所增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600812"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747177691998,"stockEarnings":[{"period":"1week","weight":-0.023},{"period":"1month","weight":0.0034},{"period":"3month","weight":-0.0434},{"period":"6month","weight":0.0531},{"period":"1year","weight":0.1423},{"period":"ytd","weight":0.1509}],"compareEarnings":[{"period":"1week","weight":0.0177},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.0085},{"period":"6month","weight":-0.0015},{"period":"1year","weight":0.0721},{"period":"ytd","weight":0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华北制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"87394人(较上一季度减少0.16%)","perCapita":"19632股","listingDate":"1994-01-14","address":"河北省石家庄市长安区和平东路388号","registeredCapital":"171573万元","survey":" 华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染类、肾病及免疫调节类、心脑血管类、维生素及健康消费品、神经、血液系统用药、医药中间体、防疫类、农药、兽药类、医药及其它物流贸易。公司是首批国家认定企业技术中心、国家“863计划”成果产业化基地、中国青年科技创新行动示范基地、微生物药物国家工程研究中心、抗体药物研制国家重点实验室、抗生素酶催化与结晶技术国家地方联合工程实验室。","listedPrice":4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华北制药,600812,华北制药股票,华北制药股票老虎,华北制药股票老虎国际,华北制药行情,华北制药股票行情,华北制药股价,华北制药股市,华北制药股票价格,华北制药股票交易,华北制药股票购买,华北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}